Morphological correlations with Nichols Institute PTH assay, comparison of biterminal and C-terminal antisera in hemodialysis patients
Gelfman, N.A.; Smith, B.; Hansen, K.
Proceedings of the Clinical Dialysis and Transplant Forum 10: 227-233
1980
ISSN/ISBN: 0094-6044 PMID: 6810346 Document Number: 167000
Document emailed within 1 workday
Related Documents
Maartens, G.; Bekker, L.G.; Sanne, I. 2001: Deciding when to institute terminal palliative care for AIDS patients--an evidence-based approach South African Medical Journal 91(7): 559-560Paul, D.; Flouret, G.; Tomita, J.T.; Ranney, K.; Schenck, J.; Anderson, B. 1981: Preparation and specificities of antisera to the amino-terminal sequence of the carcinoembryonic antigen Cancer Research 41(6): 2315-2321
Hunkeler, H.; Wegmüller, E.; Frey, B.; Hodler, J. 1977: Composition of the urine of patients with terminal renal failure before and after treatment with hemodialysis Schweizerische Medizinische Wochenschrift 107(38): 1324-1334
Van der Vijgh, W.J. 1977: Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. on hemodialysis International Journal of Clinical Pharmacology and Biopharmacy 15(6): 255-259
Nikiforov, A.S.; Soldatova, S.A.; Potomskaia, L.E.; Vinarskaia, E.N.; Ermolenko, V.M. 1977: Encephalopathy in patients with terminal renal insufficiency undergoing treatment with regular hemodialysis Terapevticheskii Arkhiv 49(7): 67-70
Potekhin, N.P. 2006: Some organizational aspects of treatment for patients with terminal renal failure having programmed hemodialysis Voenno-Meditsinskii Zhurnal 327(5): 56-59
Reis, H.E.; Heimsoth, V.H. 1973: Influence of chronic intermittent hemodialysis on lymphocyte stimulation by PHA in patients with terminal kidney failure Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 724-726
Reis, H.E.; Cremer, W.; Heimsoth, V.H.; Wetter, O.; Eitelhuber, U. 1974: Further studies on the cellular defense mechanism in patients with terminal kidney failure and on treatment using intermittent hemodialysis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 749-752
Zavgorodniĭ, S.N. 2001: Operative treatment of secondary hyperparathyroidism in patients with terminal chronic renal insufficiency in programmed hemodialysis Klinichna Khirurhiia 2001(12): 36-38
Milovanova, L.Iu.; Nikolaev, A.Iu.; Barashkov, G.K. 2001: Chronic aluminum intoxication in patients with terminal kidney failure on programmed hemodialysis (literature review) Terapevticheskii Arkhiv 73(6): 67-69
Kato, Y.; Yamaguchi, S.; Yachiku, S.; Fujisawa, M.; Kawakami, N. 2004: Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy Hinyokika Kiyo. Acta Urologica Japonica 50(11): 755-762
Chen, R.J.; Huang, S.C.; Chen, C.K.; Chang, D.Y.; Yen, M.L.; Chow, S.N.; Hsieh, C.Y. 1994: Measurement of human chorionic gonadotropin by carboxyl terminal peptide assay in patients with cervical neoplasm Journal of the Formosan Medical Association 93(11-12): 916-920
Bednarek-Skublewska, A.; Zaluska, W.; Ksiazek, A. 2010: The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients Clinical Nephrology 73(1): 14-20
Shugushev, K.Kh.; Shugushev, Z.Kh.; Khamizova, M.M.; Vasilenko, V.M. 2004: Effect of programmed hemodialysis on parameters of ventricular repolarization and cardiac rhythm disturbances in patients with terminal renal failure Kardiologiia 44(5): 67-70
Kao, P.C.; Taylor, R.L.; Heser, D.W. 1992: C-peptide immunochemiluminometric assay developed from two seemingly identical polyclonal antisera Annals of Clinical and Laboratory Science 22(5): 307-316
Curtis, J.R.; Goode, G.C.; Herrington, J.; Urdaneta, L.E. 1976: Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: a study of blood and tissue cobalt concentrations in normal subjects and patients with terminal and renal failure Clinical Nephrology 5(2): 61-65
Wollin, K-M.; Gorlitz, B-D. 2004: Comparison of genotoxicity of textile dyestuffs in Salmonella mutagenicity assay, in vitro micronucleus assay, and single cell gel/comet assay Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 23(4): 267-278
Kim, H.; Oh, E.-J.; Kang, M.-S.; Kim, S.H.; Park, Y.-J. 2007: Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers Annals of Clinical and Laboratory Science 37(3): 256-259
Fukui, A.; Kokubu, A.; Shono, F.; Tokunaga, A.; Kozakura, E. 2000: Comparison of the families of terminal stage cancer patients who underwent HPN and the nurses who cared those patients in their thoughts on home care Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 3): 687-689
Maden, E.; Bekci, T.T.; Kesli, R.; Atalay, H.; Teke, T.; Solak, Y.; Turk, S.; Uzun, K.; Koylu, R. 2011: Evaluation of performance of quantiferon assay and tuberculin skin test in end stage renal disease patients receiving hemodialysis New Microbiologica 34(4): 351-356